Cullinan Therapeutics Inc (NAS:CGEM)
$ 19.58 +1.27 (+6.94%) Market Cap: 1.26 Bil Enterprise Value: 927.60 Mil PE Ratio: 0 PB Ratio: 3.74 GF Score: 22/100

Cullinan Therapeutics Inc to Host Immunology Day Transcript

Jun 10, 2026 / 12:30 PM GMT
Release Date Price: $12.05 (-8.57%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CGEM.OQ - Cullinan Therapeutics Inc
Cullinan Therapeutics Inc to Host Immunology Day
Jun 10, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
You're awfully quiet.

Just got to wait for my signal in the back there.

Alright, well, good morning everyone and welcome to Cullinan Therapeutics Immunology Day.

Today is an important milestone for Cullinan and also the way autoimmune diseases may be treated in the future.

As you'll see. When we share the highly promising data that we've now generated across our immunology programs.

At EULAR this past weekend, we were the first company to present company-sponsored data for a CD19 T-cell engager, and today we're excited to share with you additional new data.

That is to say, the initial multi-dose data for RA, and also the first autoimmune disease data for Velinotomyc
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot